The AstraZeneca PLC ADR AZN rose 1.25% to $68.81 Friday, on what proved to be an all-around positive trading session for the ...

The AstraZeneca PLC ADR AZN slipped 2.20% to $66.23 Wednesday, on what proved to be an all-around mixed trading session for ...

(Reuters) -British equities closed higher on Friday, as the recent de-escalation of the global tariff war supported risk ...

President Donald Trump said he plans to order a cut in US prescription drug costs to bring them in line with other countries, ...

Mereo BioPharma Group plc’s MREO share price has dipped by 5.63%, which has investors questioning if this is right time to ...

President Donald Trump’s move to revive a policy that would slash Americans’ drug costs by tying them to lower prices paid ...

Pathos AI Inc., a startup using artificial intelligence to develop new oncology drugs, today announced that it has raised ...

AstraZeneca Plc lost its crown as the UK’s most valuable listed company after US President Donald Trump’s plans to lower drug prices sent shares of pharmaceuticals companies lower across the ...

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in. The content of this article is provided for information ...

Aptamer Group plc, the leading developer of next-generation synthetic binders delivering innovation to the life science ...

Harvey Jones says investment brokers showed their love for AstraZeneca shares at the start of the year, but maybe wondering if that’s been reciprocated. When investing, your capital is at risk.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...